Evidence map›Paper›PMID 38720016›Full record

ArticleLeukemia2024

Cre recombinase promotes leukemogenesis in the presence of both homozygous and heterozygous FLT3-ITD.

Min Yang, Zhiyuan Ma, Chonggang Wang, Muammer Cihan Agca, Hongyun Liu, Kezhi Huang, Silke Glage, Regina Rumpel, Alexander Gerbaulet, Axel Roers and 7 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Min Yang *Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Zhiyuan Ma *Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Chonggang Wang *Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Muammer Cihan AgcaDepartment of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Hongyun LiuDepartment of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Kezhi HuangDepartment of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Silke GlageInstitute for Laboratory Animal Science and Central Animal Facility, Hannover Medical School, Hannover, Germany.
Regina RumpelInstitute for Laboratory Animal Science and Central Animal Facility, Hannover Medical School, Hannover, Germany.
Alexander GerbauletInstitute for Immunology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.ORCID 0000-0003-4680-4920
Axel RoersInstitute for Immunology, University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0003-1806-6158
Xuemei LiuDepartment of Gastroenterology, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Fatih NoyanDepartment of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.
Nils von NeuhoffDepartment of Pediatric Hematology and Oncology, University Children's Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Arnold GanserDepartment of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Ligen LiuDepartment of Hematology, Shanghai Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Haiyang YunRobert Bosch Center for Tumor Diseases, Stuttgart, Germany. haiyang.yun@bosch-health-campus.com.
Zhixiong LiDepartment of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany. li.zhixiong@mh-hannover.de.ORCID 0000-0001-8891-3733

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) Li 1608/2-1Deutsche Forschungsgemeinschaft (German Research Foundation) Li 1608/5-1Deutsche Krebshilfe (German Cancer Aid) 108245José Carreras Leukämie-Stiftung (Deutsche José Carreras Leukämie-Stiftung) 21 R/2017
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

fms-Like Tyrosine Kinase 3HomozygoteIntegrasesAnimalsCarcinogenesisHeterozygoteHumansLeukemiaMiceMutationCre recombinaseFlt3 protein, mousefms-Like Tyrosine Kinase 3Integrases

Identifiers

PMID38720016
PMCPMC11147757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.